NEKTAR THERAPEUTICS (NKTR) › Shares OutstandingNEKTAR THERAPEUTICS (NKTR) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 94.52M2011: 114.48M2012: 115.26M2013: 116.49M2014: 131.22M2015: 135.29M2016: 153.21M2017: 159.52M2018: 173.53M2019: 176.50M2020: 180.09M2021: 185.47M2022: 188.56M2023: 191.38M2024: 12.39M2025: 20.38M20.38M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202520.38M+64.5%202412.39M-93.5%2023191.38M+1.5%2022188.56M+1.7%2021185.47M+3.0%2020180.09M+2.0%2019176.50M+1.7%2018173.53M+8.8%2017159.52M+4.1%2016153.21M+13.2%2015135.29M+3.1%2014131.22M+12.6%2013116.49M+1.1%2012115.26M+0.7%2011114.48M+21.1%201094.52M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share